Evidence and control

How ARIA handles AI uncertainty and human approval.

ARIA does not turn thin evidence into a confident answer. It assembles the public records and account context available for a named commercial question, shows the source trail behind each claim, and says when the evidence is not enough. A person reviews every prepared action before it goes out or writes back to a system.

What a reviewer should see.

Illustrative specimen using an independent fictional meeting note. No customer records or results.

Supported
The account prioritizes continuity of supply.Source trail: fictional meeting note, “Continuity of supply is our first concern.”
Unknown
Budget, required capacity and a purchasing date are not established by that note.
Needs approval
Draft a follow-up asking for the missing requirements. The owner reviews the draft before any message is sent.

Show the evidence, or show the gap.

Evidence comes before the conclusion

ARIA begins with the records available for the account and the workflow in scope. A claim in a brief, draft, or CRM-ready note should link back to the record that supports it, so the reviewer can check the basis before using it.

Thin evidence stays thin

A public record can establish that something happened without establishing every detail a commercial team would like to know. When the available evidence does not support a specific conclusion, ARIA should show the gap rather than complete the story with a plausible guess.

Approval is a handoff, not a formality

ARIA prepares work; it does not make the commercial commitment. A person decides whether a sourced brief, drafted outreach, or CRM update is correct for the account and appropriate to use.

Approved actions remain accountable

Review the prepared work, its reasoning and relevant sources before approving execution. Capture the relevant result so it can inform future work. Sent communications and some system changes may not be reversible.

Examples of evidence ARIA can use

The records depend on the workflow and customer scope. These public sources illustrate the kind of primary evidence a reviewer can inspect; they do not make every commercial conclusion knowable.

SEC EDGAR

Public company filings and Form D records can provide a dated primary record for a financing or corporate event.

ClinicalTrials.gov

Trial records can establish information that has been registered publicly, while leaving unknown details explicitly unknown.

NIH RePORTER

NIH award records can provide a primary public source for funded research activity.

Questions about control and uncertainty

What does ARIA do when the evidence is incomplete?

It should say what the available records support and what they do not support. ARIA is designed to abstain from a specific claim when the evidence is thin, rather than invent a detail to make an answer look complete.

Can ARIA send outreach without a person checking it?

No. ARIA can prepare a sourced brief and a draft, but a person approves anything that goes out or writes back into a customer system.

Can a reviewer see where an ARIA claim came from?

Yes. ARIA prepares work with a source trail so a reviewer can inspect the underlying record before using a claim in a commercial conversation.

Why is abstaining useful in life sciences commercial work?

A confident but unsupported detail can create a credibility problem with a technical buyer. An honest empty result gives the commercial team a reason to investigate further instead of presenting a guess as a fact.

Your next step

Explore how approval fits the workflow.

See an illustrative signals-to-leads film showing prepared account work and a human review step.

View the illustrative example